Literature DB >> 4306538

Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.

L H Muschel, L A Ahl, M W Fisher.   

Abstract

Strains of Pseudomonas aeruginosa isolated from clinical material were very variable in their sensitivity to the bactericidal action of normal serum mediated by the complement system. Fifty per cent killing end points ranged from 0.015 ml to greater than 0.4 ml. Most of the strains with relatively greater sensitivity to serum were isolated from patients with cystic fibrosis. Immunization of rabbits resulted in antisera with enhanced levels of bactericidal antibody, except with one strain which was resistant to the bactericidal action of normal serum and antiserum. When P. aeruginosa was cultivated at 41 C instead of at 37 C, it was significantly more sensitive to serum and to several antibiotics, thereby implicating fever as a host defense mechanism in Pseudomonas infections. In contrast to their heterogeneity to serum bactericidal activity, the strains were relatively homogeneous in their sensitivity to polymyxin, with no apparent association between their sensitivity to the two antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4306538      PMCID: PMC284838          DOI: 10.1128/jb.98.2.453-457.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

1.  Studies on the immunotherapy of bacterial infections. I. The comparative effectiveness of human gamma-globulin against various bacterial species in mice.

Authors:  M W FISHER; M C MANNING
Journal:  J Immunol       Date:  1958-07       Impact factor: 5.422

2.  Bactericidal activity of normal serum against bacterial cultures. I. Activity against Salmonella typhi strains.

Authors:  L H MUSCHEL; R H CHAMBERLIN; E OSAWA
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

3.  [Determination of the antigen O in bacteria of strain O 901].

Authors:  A M STAUB; R COMBES
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-01

4.  The agglutinating and bactericidal activity of IgM and IgG antibodies to the 9 and 12 factors of Salmonella typhi O 901.

Authors:  F Daguillard; G Edsall
Journal:  J Immunol       Date:  1968-05       Impact factor: 5.422

5.  Immunization against Pseudomonas aeruginosa. I. Induction of protection by an alcohol-precipitated fraction from the slime layer.

Authors:  T H Alms; J A Bass
Journal:  J Infect Dis       Date:  1967-06       Impact factor: 5.226

6.  The lethal events in experimental Pseudomonas aeruginosa infection of mice.

Authors:  P F Bartell; T E Orr; M Garcia
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

7.  STUDIES RELATING TO THE SERUM RESISTANCE OF CERTAIN GRAM-NEGATIVE BACTERIA.

Authors:  E OSAWA; L H MUSCHEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

8.  The combined actions of chloramphenicol and of bactericidal antibody plus complement on Salmonella typhosa.

Authors:  H P TREFFERS; L H MUSCHEL
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  8 in total
  9 in total

1.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens.

Authors:  S Beckerdite-Quagliata; M Simberkoff; P Elsbach
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

4.  Relationship between growth temperature and shedding of lipopolysaccharides by gram-negative bacilli.

Authors:  P A Mackowiak
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Optimal strategies in immunology III. The IgM-IgG switch.

Authors:  A S Perelson; B Goldstein; S Rocklin
Journal:  J Math Biol       Date:  1980-11       Impact factor: 2.259

6.  Immunization of mice and chinchillas against Pseudomonas aeruginosa.

Authors:  P I Lusis; M A Soltys
Journal:  Can J Comp Med       Date:  1971-01

7.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Hyperthermic enhancement of serum antimicrobial activity: mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis.

Authors:  P A Mackowiak; M Marling-Cason
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Role of bacterial phospholipases in serum-mediated killing of Escherichia coli.

Authors:  D L Kreutzer; M Vandermaten; C S Buller; D C Robertson; A A Hirata
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.